1 Supportive Care in Oncology Introduction and Market Overview 1.1 Objectives of the Study 1.2 Definition of Supportive Care in Oncology 1.3 Supportive Care in Oncology Market Scope and Market Size Estimation 1.3.1 Market Concentration Ratio and Market Maturity Analysis 1.3.2 Europe Supportive Care in Oncology Value and Growth Rate from 2014-2024 1.4 Market Segmentation 1.4.1 Types of Supportive Care in Oncology 1.4.2 Applications of Supportive Care in Oncology 1.4.3 Research Countries 1.5 Market Dynamics 1.5.1 Drivers 1.5.2 Limitations 1.5.3 Opportunities 1.6 Industry News and Policies by Countries 1.6.1 Industry News 1.6.2 Industry Policies 2 Industry Chain Analysis 2.1 Upstream Raw Material Suppliers of Supportive Care in Oncology Analysis 2.2 Major Players of Supportive Care in Oncology 2.2.1 Major Players Manufacturing Base and Market Share of Supportive Care in Oncology in 2018 2.2.2 Major Players Product Types in 2018 2.3 Supportive Care in Oncology Manufacturing Cost Structure Analysis 2.3.1 Consumption Process Analysis 2.3.2 Manufacturing Cost Structure of Supportive Care in Oncology 2.3.3 Raw Material Cost of Supportive Care in Oncology 2.3.4 Labor Cost of Supportive Care in Oncology 2.4 Market Channel Analysis of Supportive Care in Oncology 2.5 Major Downstream Buyers of Supportive Care in Oncology Analysis 3 Europe Supportive Care in Oncology Market, by Type 3.1 Europe Supportive Care in Oncology Value and Market Share by Type (2014-2019E) 3.2 Europe Supportive Care in Oncology Consumption and Market Share by Type (2014-2019E) 3.3 Europe Supportive Care in Oncology Value and Growth Rate by Type (2014-2019E) 3.3.1 Europe Supportive Care in Oncology Value and Growth Rate of Opioid analgesics 3.3.2 Europe Supportive Care in Oncology Value and Growth Rate of Nonsteroidal erythropoietin stimulating agents 3.3.3 Europe Supportive Care in Oncology Value and Growth Rate of Anti-infective drugs 3.3.4 Europe Supportive Care in Oncology Value and Growth Rate of Anti-imflammatory drugs 3.3.5 Europe Supportive Care in Oncology Value and Growth Rate of Bisphosphonates 3.3.6 Europe Supportive Care in Oncology Value and Growth Rate of Monoclonal antibodies 3.3.7 Europe Supportive Care in Oncology Value and Growth Rate of Anti-emetics drugs 3.3.8 Europe Supportive Care in Oncology Value and Growth Rate of Granulocyte colony stimulating factor 3.4 Europe Supportive Care in Oncology Price Analysis by Type (2014-2019E) 4 Supportive Care in Oncology Market, by Application 4.1 Downstream Market Overview 4.2 Europe Supportive Care in Oncology Consumption and Market Share by Application (2014-2019E) 4.2.1 Europe Supportive Care in Oncology Consumption and Growth Rate of Lung cancer (2014-2019E) 4.2.2 Europe Supportive Care in Oncology Consumption and Growth Rate of Prostate cancer (2014-2019E) 4.2.3 Europe Supportive Care in Oncology Consumption and Growth Rate of Breast cancer (2014-2019E) 4.2.4 Europe Supportive Care in Oncology Consumption and Growth Rate of Ovarian cancer (2014-2019E) 4.2.5 Europe Supportive Care in Oncology Consumption and Growth Rate of Leukemia (2014-2019E) 4.2.6 Europe Supportive Care in Oncology Consumption and Growth Rate of Bladder cancer (2014-2019E) 4.2.7 Europe Supportive Care in Oncology Consumption and Growth Rate of Liver cancer (2014-2019E) 4.2.8 Europe Supportive Care in Oncology Consumption and Growth Rate of Melanoma (2014-2019E) 4.2.9 Europe Supportive Care in Oncology Consumption and Growth Rate of Others (2014-2019E) 5 Europe Supportive Care in Oncology Consumption, Value ($) by Countries (2014-2019E) 5.1 Europe Supportive Care in Oncology Value and Market Share by Countries (2014-2019E) 5.2 Europe Supportive Care in Oncology Consumption and Market Share by Countries (2014-2019E) 5.3 Europe Supportive Care in Oncology Consumption, Value, Price and Gross Margin (2014-2019E) 5.4 Germany Supportive Care in Oncology Consumption, Value, Price and Gross Margin (2014-2019E) 5.5 UK Supportive Care in Oncology Consumption, Value, Price and Gross Margin (2014-2019E) 5.6 France Supportive Care in Oncology Consumption, Value, Price and Gross Margin (2014-2019E) 5.7 Italy Supportive Care in Oncology Consumption, Value, Price and Gross Margin (2014-2019E) 5.8 Spain Supportive Care in Oncology Consumption, Value, Price and Gross Margin (2014-2019E) 5.9 Russia Supportive Care in Oncology Consumption, Value, Price and Gross Margin (2014-2019E) 6 Competitive Landscape 6.1 Competitive Profile 6.2 Kyowa Hakko Kirin Co Ltd. 6.2.1 Company Profiles 6.2.2 Supportive Care in Oncology Product Introduction 6.2.3 Kyowa Hakko Kirin Co Ltd. Sales, Value, Price, Gross Margin 2014-2019E 6.2.4 Kyowa Hakko Kirin Co Ltd. Market Share of Supportive Care in Oncology Segmented by Region in 2018 6.3 Novartis Ag. 6.3.1 Company Profiles 6.3.2 Supportive Care in Oncology Product Introduction 6.3.3 Novartis Ag. Sales, Value, Price, Gross Margin 2014-2019E 6.3.4 Novartis Ag. Market Share of Supportive Care in Oncology Segmented by Region in 2018 6.4 Amgen Inc. 6.4.1 Company Profiles 6.4.2 Supportive Care in Oncology Product Introduction 6.4.3 Amgen Inc. Sales, Value, Price, Gross Margin 2014-2019E 6.4.4 Amgen Inc. Market Share of Supportive Care in Oncology Segmented by Region in 2018 6.5 Fagron Group BV 6.5.1 Company Profiles 6.5.2 Supportive Care in Oncology Product Introduction 6.5.3 Fagron Group BV Sales, Value, Price, Gross Margin 2014-2019E 6.5.4 Fagron Group BV Market Share of Supportive Care in Oncology Segmented by Region in 2018 6.6 Baxter International Inc 6.6.1 Company Profiles 6.6.2 Supportive Care in Oncology Product Introduction 6.6.3 Baxter International Inc Sales, Value, Price, Gross Margin 2014-2019E 6.6.4 Baxter International Inc Market Share of Supportive Care in Oncology Segmented by Region in 2018 6.7 Johnson & Johnson 6.7.1 Company Profiles 6.7.2 Supportive Care in Oncology Product Introduction 6.7.3 Johnson & Johnson Sales, Value, Price, Gross Margin 2014-2019E 6.7.4 Johnson & Johnson Market Share of Supportive Care in Oncology Segmented by Region in 2018 6.8 APR Applied Pharma Science Research S.A. 6.8.1 Company Profiles 6.8.2 Supportive Care in Oncology Product Introduction 6.8.3 APR Applied Pharma Science Research S.A. Sales, Value, Price, Gross Margin 2014-2019E 6.8.4 APR Applied Pharma Science Research S.A. Market Share of Supportive Care in Oncology Segmented by Region in 2018 6.9 Hoffmann LA- Roche Ltd 6.9.1 Company Profiles 6.9.2 Supportive Care in Oncology Product Introduction 6.9.3 Hoffmann LA- Roche Ltd Sales, Value, Price, Gross Margin 2014-2019E 6.9.4 Hoffmann LA- Roche Ltd Market Share of Supportive Care in Oncology Segmented by Region in 2018 6.10 Acacia Pharma Ltd. 6.10.1 Company Profiles 6.10.2 Supportive Care in Oncology Product Introduction 6.10.3 Acacia Pharma Ltd. Sales, Value, Price, Gross Margin 2014-2019E 6.10.4 Acacia Pharma Ltd. Market Share of Supportive Care in Oncology Segmented by Region in 2018 6.11 Teva Pharmaceuticals Industries Ltd 6.11.1 Company Profiles 6.11.2 Supportive Care in Oncology Product Introduction 6.11.3 Teva Pharmaceuticals Industries Ltd Sales, Value, Price, Gross Margin 2014-2019E 6.11.4 Teva Pharmaceuticals Industries Ltd Market Share of Supportive Care in Oncology Segmented by Region in 2018 7 Europe Supportive Care in Oncology Market Analysis and Forecast by Type and Application 7.1 Europe Supportive Care in Oncology Market Value & Volume Forecast, by Type (2019-2024) 7.1.1 Opioid analgesics Market Value and Volume Forecast (2019-2024) 7.1.2 Nonsteroidal erythropoietin stimulating agents Market Value and Volume Forecast (2019-2024) 7.1.3 Anti-infective drugs Market Value and Volume Forecast (2019-2024) 7.1.4 Anti-imflammatory drugs Market Value and Volume Forecast (2019-2024) 7.1.5 Bisphosphonates Market Value and Volume Forecast (2019-2024) 7.1.6 Monoclonal antibodies Market Value and Volume Forecast (2019-2024) 7.1.7 Anti-emetics drugs Market Value and Volume Forecast (2019-2024) 7.1.8 Granulocyte colony stimulating factor Market Value and Volume Forecast (2019-2024) 7.2 Europe Supportive Care in Oncology Market Value & Volume Forecast, by Application (2019-2024) 7.2.1 Lung cancer Market Value and Volume Forecast (2019-2024) 7.2.2 Prostate cancer Market Value and Volume Forecast (2019-2024) 7.2.3 Breast cancer Market Value and Volume Forecast (2019-2024) 7.2.4 Ovarian cancer Market Value and Volume Forecast (2019-2024) 7.2.5 Leukemia Market Value and Volume Forecast (2019-2024) 7.2.6 Bladder cancer Market Value and Volume Forecast (2019-2024) 7.2.7 Liver cancer Market Value and Volume Forecast (2019-2024) 7.2.8 Melanoma Market Value and Volume Forecast (2019-2024) 7.2.9 Others Market Value and Volume Forecast (2019-2024) 8 Supportive Care in Oncology Market Analysis and Forecast by Countries 8.1 Germany Market Value and Consumption Forecast (2019-2024) 8.2 UK Market Value and Consumption Forecast (2019-2024) 8.3 France Market Value and Consumption Forecast (2019-2024) 8.4 Italy Market Value and Consumption Forecast (2019-2024) 8.5 Spain Market Value and Consumption Forecast (2019-2024) 8.6 Russia Market Value and Consumption Forecast (2019-2024) 9 New Project Feasibility Analysis 9.1 Industry Barriers and New Entrants SWOT Analysis 9.2 Analysis and Suggestions on New Project Investment 10 Research Finding and Conclusion 11 Appendix 11.1 Methodology 11.2 Research Data Source

List of Tables and Figures Figure Product Picture of Supportive Care in Oncology Table Product Specification of Supportive Care in Oncology Figure Market Concentration Ratio and Market Maturity Analysis of Supportive Care in Oncology Figure Europe Supportive Care in Oncology Value ($) and Growth Rate from 2014-2024 Table Different Types of Supportive Care in Oncology Figure Europe Supportive Care in Oncology Value ($) Segment by Type from 2014-2019E Figure Europe Supportive Care in Oncology Market Share by Types in 2018 Figure Opioid analgesics Picture Figure Nonsteroidal erythropoietin stimulating agents Picture Figure Anti-infective drugs Picture Figure Anti-imflammatory drugs Picture Figure Bisphosphonates Picture Figure Monoclonal antibodies Picture Figure Anti-emetics drugs Picture Figure Granulocyte colony stimulating factor Picture Table Different Applications of Supportive Care in Oncology Figure Europe Supportive Care in Oncology Value ($) Segment by Applications from 2014-2019E Figure Europe Supportive Care in Oncology Market Share by Applications in 2018 Figure Lung cancer Picture Figure Prostate cancer Picture Figure Breast cancer Picture Figure Ovarian cancer Picture Figure Leukemia Picture Figure Bladder cancer Picture Figure Liver cancer Picture Figure Melanoma Picture Figure Others Picture Table Research Countries of Supportive Care in Oncology Figure Europe Supportive Care in Oncology Market Share by Countries in 2018 Figure Germany Supportive Care in Oncology Consumption Value ($) and Growth Rate (2014-2019E) Figure UK Supportive Care in Oncology Consumption Value ($) and Growth Rate (2014-2019E) Figure France Supportive Care in Oncology Consumption Value ($) and Growth Rate (2014-2019E) Figure Italy Supportive Care in Oncology Consumption Value ($) and Growth Rate (2014-2019E) Figure Spain Supportive Care in Oncology Consumption Value ($) and Growth Rate (2014-2019E) Figure Russia Supportive Care in Oncology Consumption Value ($) and Growth Rate (2014-2019E) Table Emerging and Growing Market of Supportive Care in Oncology Table Industry News Table Industry Policies Figure Industry Chain Analysis of Supportive Care in Oncology Table Upstream Raw Material Suppliers of Supportive Care in Oncology with Contact Information Table Major Players Manufacturing Base and Market Share of Supportive Care in Oncology in 2018 Table Major Players Consumption Value Market Share of Supportive Care in Oncology in 2018 Table Major Players Supportive Care in Oncology Product Types in 2018 Figure Consumption Process of Supportive Care in Oncology Figure Manufacturing Cost Structure of Supportive Care in Oncology Figure Channel Status of Supportive Care in Oncology Table Major Distributors of Supportive Care in Oncology with Contact Information Table Major Downstream Buyers of Supportive Care in Oncology with Contact Information Table Europe Supportive Care in Oncology Value ($) by Type (2014-2019E) Table Europe Supportive Care in Oncology Value Share by Type (2014-2019E) Figure Europe Supportive Care in Oncology Value Share by Type (2014-2019E) Table Europe Supportive Care in Oncology Consumption by Type (2014-2019E) Table Europe Supportive Care in Oncology Consumption Share by Type (2014-2019E) Figure Europe Supportive Care in Oncology Consumption Share by Type (2014-2019E) Figure Opioid analgesics Picture Figure Nonsteroidal erythropoietin stimulating agents Picture Figure Anti-infective drugs Picture Figure Anti-imflammatory drugs Picture Figure Bisphosphonates Picture Figure Monoclonal antibodies Picture Figure Anti-emetics drugs Picture Figure Granulocyte colony stimulating factor Picture Figure Europe Supportive Care in Oncology Value ($) and Growth Rate of Granulocyte colony stimulating factor Table Europe Supportive Care in Oncology Price by Type (2014-2019E) Figure Downstream Market Overview Table Europe Supportive Care in Oncology Consumption by Application (2014-2019E) Table Europe Supportive Care in Oncology Consumption Market Share by Application (2014-2019E) Figure Europe Supportive Care in Oncology Consumption Market Share by Application (2014-2019E) Figure Europe Supportive Care in Oncology Consumption and Growth Rate of Lung cancer (2014-2019) Figure Europe Supportive Care in Oncology Consumption and Growth Rate of Prostate cancer (2014-2019) Figure Europe Supportive Care in Oncology Consumption and Growth Rate of Breast cancer (2014-2019) Figure Europe Supportive Care in Oncology Consumption and Growth Rate of Ovarian cancer (2014-2019) Figure Europe Supportive Care in Oncology Consumption and Growth Rate of Leukemia (2014-2019) Figure Europe Supportive Care in Oncology Consumption and Growth Rate of Bladder cancer (2014-2019) Figure Europe Supportive Care in Oncology Consumption and Growth Rate of Liver cancer (2014-2019) Figure Europe Supportive Care in Oncology Consumption and Growth Rate of Melanoma (2014-2019) Figure Europe Supportive Care in Oncology Consumption and Growth Rate of Others (2014-2019) Table Europe Supportive Care in Oncology Value ($) by Countries (2014-2019E) Table Europe Supportive Care in Oncology Value Market Share by Countries (2014-2019E) Figure Europe Supportive Care in Oncology Value Market Share by Countries (2014-2019E) Table Europe Supportive Care in Oncology Consumption by Countries (2014-2019E) Table Europe Supportive Care in Oncology Consumption Market Share by Countries (2014-2019E) Figure Europe Supportive Care in Oncology Consumption Market Share by Countries (2014-2019E) Table Europe Supportive Care in Oncology Consumption, Value, Price and Gross Margin (2014-2019E) Table Germany Supportive Care in Oncology Consumption, Value, Price and Gross Margin (2014-2019E) Table UK Supportive Care in Oncology Consumption, Value, Price and Gross Margin (2014-2019E) Table France Supportive Care in Oncology Consumption, Value, Price and Gross Margin (2014-2019E) Table Italy Supportive Care in Oncology Consumption, Value, Price and Gross Margin (2014-2019E) Table Spain Supportive Care in Oncology Consumption, Value, Price and Gross Margin (2014-2019E) Table Russia Supportive Care in Oncology Consumption, Value, Price and Gross Margin (2014-2019E) Figure Top 3 Market Share of Supportive Care in Oncology Companies in 2018 Figure Top 6 Market Share of Supportive Care in Oncology Companies in 2018 Table Major Players Value ($) Share (2014-2019E) Table Company Profiles Table Product Introduction Table Kyowa Hakko Kirin Co Ltd. Sales, Value, Price, Gross Margin 2014-2019E Figure Kyowa Hakko Kirin Co Ltd. Sales and Growth Rate Figure Kyowa Hakko Kirin Co Ltd. Value ($) Market Share 2014-2019 Figure Kyowa Hakko Kirin Co Ltd. Market Share of Supportive Care in Oncology Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Novartis Ag. Sales, Value, Price, Gross Margin 2014-2019E Figure Novartis Ag. Sales and Growth Rate Figure Novartis Ag. Value ($) Market Share 2014-2019 Figure Novartis Ag. Market Share of Supportive Care in Oncology Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Amgen Inc. Sales, Value, Price, Gross Margin 2014-2019E Figure Amgen Inc. Sales and Growth Rate Figure Amgen Inc. Value ($) Market Share 2014-2019 Figure Amgen Inc. Market Share of Supportive Care in Oncology Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Fagron Group BV Sales, Value, Price, Gross Margin 2014-2019E Figure Fagron Group BV Sales and Growth Rate Figure Fagron Group BV Value ($) Market Share 2014-2019 Figure Fagron Group BV Market Share of Supportive Care in Oncology Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Baxter International Inc Sales, Value, Price, Gross Margin 2014-2019E Figure Baxter International Inc Sales and Growth Rate Figure Baxter International Inc Value ($) Market Share 2014-2019 Figure Baxter International Inc Market Share of Supportive Care in Oncology Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Johnson & Johnson Sales, Value, Price, Gross Margin 2014-2019E Figure Johnson & Johnson Sales and Growth Rate Figure Johnson & Johnson Value ($) Market Share 2014-2019 Figure Johnson & Johnson Market Share of Supportive Care in Oncology Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table APR Applied Pharma Science Research S.A. Sales, Value, Price, Gross Margin 2014-2019E Figure APR Applied Pharma Science Research S.A. Sales and Growth Rate Figure APR Applied Pharma Science Research S.A. Value ($) Market Share 2014-2019 Figure APR Applied Pharma Science Research S.A. Market Share of Supportive Care in Oncology Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Hoffmann LA- Roche Ltd Sales, Value, Price, Gross Margin 2014-2019E Figure Hoffmann LA- Roche Ltd Sales and Growth Rate Figure Hoffmann LA- Roche Ltd Value ($) Market Share 2014-2019 Figure Hoffmann LA- Roche Ltd Market Share of Supportive Care in Oncology Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Acacia Pharma Ltd. Sales, Value, Price, Gross Margin 2014-2019E Figure Acacia Pharma Ltd. Sales and Growth Rate Figure Acacia Pharma Ltd. Value ($) Market Share 2014-2019 Figure Acacia Pharma Ltd. Market Share of Supportive Care in Oncology Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Teva Pharmaceuticals Industries Ltd Sales, Value, Price, Gross Margin 2014-2019E Figure Teva Pharmaceuticals Industries Ltd Sales and Growth Rate Figure Teva Pharmaceuticals Industries Ltd Value ($) Market Share 2014-2019 Figure Teva Pharmaceuticals Industries Ltd Market Share of Supportive Care in Oncology Segmented by Region in 2018 Table Europe Supportive Care in Oncology Market Value ($) Forecast, by Type Table Europe Supportive Care in Oncology Market Volume Forecast, by Type Table Europe Market Value ($) Forecast by Application (2019-2024) Table Europe Market Volume Forecast by Application (2019-2024) Figure Germany Market Value ($) and Growth Rate Forecast (2019-2024) Figure Germany Consumption and Growth Rate Forecast (2019-2024) Figure UK Market Value ($) and Growth Rate Forecast (2019-2024) Figure UK Consumption and Growth Rate Forecast (2019-2024) Figure France Market Value ($) and Growth Rate Forecast (2019-2024) Figure France Consumption and Growth Rate Forecast (2019-2024) Figure Italy Market Value ($) and Growth Rate Forecast (2019-2024) Figure Italy Consumption and Growth Rate Forecast (2019-2024) Figure Spain Market Value ($) and Growth Rate Forecast (2019-2024) Figure Spain Consumption and Growth Rate Forecast (2019-2024) Figure Russia Market Value ($) and Growth Rate Forecast (2019-2024) Figure Russia Consumption and Growth Rate Forecast (2019-2024) Figure Industry Resource/Technology/Labor Importance Analysis Table New Entrants SWOT Analysis Table New Project Analysis of Investment Recovery